Investor Stock List
Ranked #7,388 of 8,699 institutional investors

Exome Asset Management LLC

New York, NY

$136M
US stock portfolio at live prices · today −$1.2M (−0.87%)
Live prices, last trade 9:41 AM ET
Value at quarter end (Q3 2026)
$153M
Change from Q2 2026
−$9.1M (−5.60%)
Positions
51 · 9 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$4.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
TGTX 8.97%GH 7.07%PRAX 6.70%LLY 5.51%ABVX 5.30%
StockSharesValue, live% of portfoliovs Q2 2026
TGTX TG Therapeutics, Inc.187,671$12.2M8.97%Added +14%
GH Guardant Health, Inc.67,500$9.6M7.07%Unchanged
PRAX Praxis Precision Medicines, Inc.29,681$9.1M6.70%Added +9%
LLY Eli Lilly and Company5,492$7.5M5.51%Unchanged
ABVX ABIVAX Société Anonyme90,919$7.2M5.30%Added +94%
COGT Cogent Biosciences, Inc.210,523$5.7M4.22%Unchanged
ELVN Enliven Therapeutics, Inc.100,203$4.7M3.43%Unchanged
VERA Vera Therapeutics, Inc.159,556$4.3M3.13%Added +64%
NTRA Natera, Inc.13,800$3.9M2.88%Unchanged
VKTX Viking Therapeutics, Inc.147,497$3.8M2.81%Added +208%
RYTM Rhythm Pharmaceuticals, Inc.32,209$3.7M2.74%Unchanged
MAZE Maze Therapeutics, Inc.114,692$3.7M2.69%Unchanged
LQDA Liquidia Corporation59,155$3.3M2.45%Added +51%
CYTK Cytokinetics, Incorporated60,056$3.1M2.30%Unchanged
IONS Ionis Pharmaceuticals, Inc.107,034$3.0M2.17%Added +21%
VSTM Verastem, Inc.429,041$2.9M2.11%Unchanged
CAI Caris Life Sciences, Inc.146,093$2.6M1.94%Added +87%
GKOS Glaukos Corporation10,862$2.5M1.88%Reduced −45%
NKTR Nektar Therapeutics73,708$2.4M1.74%Added +229%
UTHR United Therapeutics Corporation4,109$2.3M1.70%Reduced −24%
BSX Boston Scientific Corporation48,347$2.1M1.53%Unchanged
PEN Penumbra, Inc.6,300$2.0M1.48%Unchanged
ISRG Intuitive Surgical, Inc.4,908$2.0M1.48%Unchanged
UNH UnitedHealth Group Incorporated5,697$1.9M1.43%Reduced −41%
MLTX MoonLake Immunotherapeutics166,493$1.8M1.34%Unchanged
MRK Merck & Co., Inc.12,358$1.7M1.23%New
BBIO BridgeBio Pharma, Inc.21,209$1.6M1.21%Added +16%
TXG 10x Genomics, Inc.30,074$1.6M1.19%Reduced −71%
OCUL Ocular Therapeutix, Inc.272,046$1.6M1.17%Added +50%
CLDX Celldex Therapeutics, Inc.56,269$1.5M1.13%New
ARWR Arrowhead Pharmaceuticals, Inc.32,214$1.4M1.04%Unchanged
REPL Replimune Group, Inc.68,488$1.3M0.96%Added +70%
GLUE Monte Rosa Therapeutics, Inc.137,015$1.2M0.90%Unchanged
ALMS Alumis Inc.282,253$1.2M0.89%Added +38%
CMPS COMPASS Pathways plc153,087$1.2M0.88%New
PVLA Palvella Therapeutics, Inc.7,809$1.1M0.84%New
CTMX CytomX Therapeutics, Inc.460,067$948K0.70%Unchanged
ZBIO Zenas BioPharma, Inc.34,341$863K0.64%Reduced −35%
BLLN BillionToOne, Inc.8,983$805K0.59%New
CLPT ClearPoint Neuro, Inc.110,174$803K0.59%Added +32%
RAPP Rapport Therapeutics, Inc.29,381$695K0.51%New
CLYM Climb Bio Inc71,215$645K0.47%New
EQ Equillium, Inc.552,956$622K0.46%Unchanged
QTTB Q32 Bio Inc.62,589$520K0.38%New
NBP NovaBridge Biosciences576,960$502K0.37%Unchanged
CRBP Corbus Pharmaceuticals Holdings, Inc.190,714$456K0.34%Added +3%
CAPR Capricor Therapeutics, Inc.51,531$398K0.29%New
CMPX Compass Therapeutics, Inc.511,084$347K0.26%Added +85%
DRUG Bright Minds Biosciences Inc.14,715$298K0.22%Added +46%
ABUS Arbutus Biopharma Corporation50,166$203K0.15%Unchanged
ADAG Adagene Inc.52,543$104K<0.1%Reduced −89%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
AGIO Agios Pharmaceuticals, Inc.70,500$2.0M
INSM Insmed Incorporated13,873$2.0M
RLAY Relay Therapeutics, Inc.47,531$751K
GERN Geron Corporation624,046$572K